Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis in a renal transplant patient-beyond the usual.

Clinical kidney journal·2018
Same author

Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations.

Kidney international·2007
Same author

Cholesterol crystal embolism: diagnosis and treatment.

Kidney international·2006
Same author

Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP).

Journal of medical genetics·2004
Same author

Sarcoidosis: the nephrologist's view.

Annales de medecine interne·2001
Same author

Pharmacokinetics of quinupristin/ dalfopristin in patients with severe chronic renal insufficiency.

Clinical pharmacokinetics·2000

Related Experiment Videos

Hypertensive nephrosclerosis pathogenesis, diagnosis and management.

A Meyrier1

  • 1Service de Nephrologie and INSERM U 430, University Hopital Broussais, Paris, France.

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
|January 24, 2008
PubMed
Summary

Nephrosclerosis, often overdiagnosed, may stem from genetic defects, not just hypertension. Early interventions targeting blood pressure and sclerosis are crucial for managing this condition.

Related Experiment Videos

Area of Science:

  • Nephrology
  • Vascular Biology
  • Genetics

Background:

  • Neph vascu lopathies are a growing cause of end-stage renal failure.
  • Hypertensive nephrosclerosis is a frequently overdiagnosed condition, as renal vascular lesions can occur independently of hypertension.
  • Conditions like atherosclerotic renal disease and cholesterol crystal embolism are often misdiagnosed as nephrosclerosis.

Purpose of the Study:

  • To clarify the diagnostic criteria for nephrosclerosis.
  • To explore the potential genetic underpinnings of nephrosclerosis.
  • To discuss current and future treatment strategies for nephrosclerosis.

Main Methods:

  • Review of existing literature on nephrosclerosis and related conditions.
  • Analysis of clinical presentations and pathological findings.
  • Consideration of recent research on low birthweight and hypertension.

Main Results:

  • Nephrosclerosis is frequently misdiagnosed, with similar lesions observed in the absence of hypertension, suggesting a potential genetic component.
  • The classical presentation involves arterio- and arteriolonephrosclerosis, glomerulosclerosis, fibrosis, and inflammation, but these are not exclusive to hypertensive cases.
  • Low birthweight and early-onset hypertension may offer insights into nephrosclerosis pathogenesis.

Conclusions:

  • Nephrosclerosis diagnosis requires careful consideration beyond hypertension, potentially involving renal biopsy.
  • Genetic factors may play a significant role in renal vascular disease development.
  • Treatment should focus on blood pressure control and sclerosis retardation using agents like angiotensin II antagonists.